PSYC Revamps Their Online Presence with a Relaunch of Corporate Website
— Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the Company has completed the redevelopment and relaunch …
Tag: investing in psychedelic companies
Revive Therapeutics Announces IRB Approval of US Expanded Access Treatment Program (Compassionate Use) for Bucillamine in COVID-19
— Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics …
Mydecine Innovations Group, Inc. to Create Special Committee for the Spin Out of US Related Assets
— Mydecine Innovations Group Inc. (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”), today announced the Company has formed a special committee to evaluate a number …
Numinus Announces Closing of Oversubscribed $4.6 Million Offering
– Numinus Wellness Inc. (“Numinus” or the “Company“) (TSXV: NUMI), is pleased to announce that it has closed its previously announced short form prospectus offering, on …
Revive Therapeutics Announces IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19
— Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics …
Numinus Files Restated Financial Reports
– Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI) announces that as a result of a review by the Company’s auditors in connection with its …
Hollister Biosciences Inc. Reports Second Quarter 2020 Results
Multi-state operator and diversified cannabis branding company generates record quarterly revenue and delivers profitable second quarter – Hollister Biosciences Inc. (CSE: HOLL), (OTC: HSTRF), (FRANKFURT: HOB) (the “Company“, …
Nutritional High Announces Settlement of Payables and Update on Psychedelic Sciences Corp Acquisition.
– Nutritional High International Inc. (CSE: EAT) (OTC Pink: SPLIF) (“Nutritional High” or the “Company“)is pleased to announce settlement of trade payables and an update regarding the …
Mydecine Innovations Group Adds Former Pfizer, Novartis, Yale Drug Discovery Expert to Scientific Advisory Board
— Mydecine Innovations Group Inc. (CSE: MYCO) (OTC: MYCOF) (FSE:0NF) (“Mydecine” or the “Company”), is pleased to announce that it has added world renowned drug …